FTC judge says Impax should settle
Federal Trade Commission building (Credit: Wikimedia)
Impax Laboratories should settle the Federal Trade Commission’s allegations that it entered into a pay-for-delay agreement with Endo Pharmaceuticals, an administrative law judge suggested on Thursday.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10